Login / Signup

Identifying risk factors associated with worse outcomes in adolescents and young adults undergoing hematopoietic stem cell transplantation.

Brian D FriendKevin TangDaniela MarkovicDavid ElashoffTheodore B MooreGary J Schiller
Published in: Pediatric blood & cancer (2019)
The comorbidities included in the HCT-CI as well as additional risk factors seen in younger populations need to be studied in prospective studies with the goal of validating and refining a risk score specific to AYA patients undergoing allogeneic HSCT.
Keyphrases
  • risk factors
  • patients undergoing
  • hematopoietic stem cell
  • stem cell transplantation
  • bone marrow
  • acute myeloid leukemia
  • cell cycle arrest
  • high dose
  • genetic diversity
  • cell death
  • low dose
  • skeletal muscle